Q: Medicago (MDG), a Canadian biotech company developing human vaccines using plant-like virus particles, has just shot forward ~20% (to $1.15) on news that Mitsubishi and Philip Morris will buy 54% of the company for ~$175 million, closing this Fall. I wonder if it is wise to sell now or stay with it hoping for even better returns in the years ahead. Indeed, I wonder if I will have a choice - I assume I will not have to tender since only 54% is being sold. Will they issue additional shares if not enough present owners tender?
I do not know if this kind of company is outside your interests, but I would certainly appreciate your comments.
Thanks for your great service, Bob.
I do not know if this kind of company is outside your interests, but I would certainly appreciate your comments.
Thanks for your great service, Bob.